Nevro P/E Ratio

Nevro (NVRO) currently reports a P/E ratio of -1.91. That is below the Healthcare sector average of 77.98. Use the charts on this page to explore Nevro's P/E ratio history and peer comparisons.

Nevro's P/E ratio of -1.91 is lower than the Healthcare sector average of 77.98. That is roughly 102.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Nevro's market price to a fundamental measure such as earnings, sales, or book value. At -1.91, NVRO can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -1.91, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 77.98. From there, open related valuation or income-statement pages for Nevro, and consider following NVRO for alerts when major investors trade the stock.

Nevro is classified in the Healthcare sector. On P/E ratio, it currently shows -1.91 versus a sector average near 77.98. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NVRO with unrelated industries.